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Abstract Big leaps in science happen when scientists
from different backgrounds interact. In the past 15 years,
the FANTOM Consortium has brought together scientists
from different fields to analyze and interpret genomic data
produced with novel technologies, including mouse full-
length cDNAs and, more recently, expression profiling at
single-nucleotide resolution by cap-analysis gene expres-
sion. The FANTOM Consortium has provided the most
comprehensive mouse cDNA collection for functional
studies and extensive maps of the human and mouse
transcriptome comprising promoters, enhancers, as well as
the network of their regulatory interactions. More impor-
tantly, serendipitous observations of the FANTOM dataset
led us to realize that the mammalian genome is pervasively
transcribed, even from retrotransposon elements, which
were previously considered junk DNA. The majority of
products from the mammalian genome are long non-coding
RNAs (lncRNAs), including sense-antisense, intergenic,
and enhancer RNAs. While the biological function has
been elucidated for some lncRNAs, more than 98 % of
them remain without a known function. We argue that
large-scale studies are urgently needed to address the
functional role of lncRNAs.
Pre-FANTOM Era
In the 1990’s, mouse genetics was considered a powerful
tool to discover genes responsible for phenotypes and
ultimately to model function of disease-related genes.
However, such gene hunting was based on positional
cloning, which required laborious work of a skilled
researcher to identify causative genes of a given phenotype
(Collins 1995). Accelerating this process required the
development of genetic maps as well as a complete set of
transcribed genes to overlay these DNA maps. Realizing
the need of the community for a comprehensive description
of the mammalian genome, RIKEN decided to enter and
contribute to the emerging area of genomics by focusing on
the transcriptome rather than on genome sequencing. Thus,
in 1995 RIKEN embarked on the mouse genome ency-
clopedia project with the aim to produce the broadest
collection of full-length cDNA. This also generated a
resource for future experiments, such as the expression of
cDNAs for functional studies (Shin et al. 2012; Suzuki
et al. 2012), structure determination of the proteins (Kasai
et al. 2004), and applied sciences such as induced
pluripotent stem (iPS) cells (The Bungeishunju 2010;
Newton 2012).
For this project to succeed, it was crucial to develop a
series of experimental protocols to efficiently reverse-
transcribe the complete transcript, generating full-length
cDNAs. A particular problem was that the reverse tran-
scriptase tends to dissociate from the transcript when it
encounters secondary structures in the RNA, which resul-
ted in truncated cDNAs. Simply increasing the temperature
of the reverse transcription reaction to dissolve such sec-
ondary structures led to inactivation of the reverse tran-
scriptase. We overcame this challenge by establishing a
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the enzymatic activity of the reverse transcriptase at higher
temperatures (Carninci et al. 1998, 2002). Complementary
to this methodology, we further developed (1) The cap-
trapper method to select for full-length cDNAs while
avoiding truncated ones (Carninci et al. 1996, 1997), (2) a
vector system able to host long cDNA clones that can
shuttle them from a lambda phage to a plasmid without
size or sequence bias (Carninci et al. 2001), and (3)
methods to ensure the inclusion of the very first transcribed
nucleotide (Shibata et al. 2001).
In parallel to establishing the experimental protocols, we
also developed the RIKEN integrated sequence analysis
(RISA) 384 multicapillary sequencer—the only capillary
sequencing instrument able to sequence 384 cDNAs in
parallel (Shibata et al. 2000, 2001)—as well as the plasmid
extractor instrument (Itoh et al. 1999), which was used to
generate and sequence 40,000 clones per day to screen for
novel cDNAs.
However, in our quest to build the broadest cDNA
collection, we were faced with a new challenge: cDNA
libraries resulted in sequencing the same highly expressed
transcripts repeatedly while missing lowly expressed tran-
scripts. It therefore became essential to find a way to enrich
for lowly expressed and novel transcripts in the cDNA
libraries while avoiding cDNAs that had already been
sequenced. For this purpose we devised a method to nor-
malize and subtract full-length cDNA libraries (Carninci
et al. 2000), which was later expanded into a reiterative
subtraction strategy using even a small amount of cDNA
(Hirozane-Kishikawa et al. 2003). After sequencing a
cDNA library, we rearrayed the novel cDNAs and used
them to produce an RNA driver that was employed to
remove these cDNAs for the next series of libraries. Reit-
eration of this process, with a growing pool of cDNA used
as driver, allowed us to progressively discover novel
RNAs, including rare transcripts (Carninci et al. 2003). In
total, we produced 246 normalized, subtracted cDNA
libraries from a wide collection of mouse tissues and cells,
which were ideal as it also allowed sampling of develop-
mental stages and rare tissues, including tiny nervous tis-
sues, to ensure the largest coverage possible.
We started sequencing the initial libraries in 1998, and
by 1999, the collection was already rich with a large
number of ESTs as well as full-length cDNAs. However,
while the project continued as a huge technical success for
making and sequencing cDNAs, the bioinformatics analy-
sis was not well considered at that time. For most novel
cDNA sequences, BLAST against GenBank resulted in the
uninformative ‘‘similar to EST’’ output. Thus, we were
discovering novel mammalian transcripts at an unprece-
dented rate but were unable to annotate them.
FANTOM1: The first annotation of full-length
cDNAs
To address this concern, we decided to contact Gerry
Rubin, who had organized the first genome annotation
effort, the Drosophila melanogaster ‘‘jamboree’’ (Adams
et al. 2000). His advice convinced us of the need for an
integrated annotation process involving both computational
predictions as well as manual curation by scientists with
expertise in specific aspects of biology. In a few months,
we arranged the first Functional Annotation of the Mouse
(later Mammalian) Genome (FANTOM1) consortium
meeting in Tsukuba (Ibaraki, Japan; August 28–September
8, 2000), where we annotated the first set of *20,000
cDNAs and developed bioinformatics tools for annotation.
The FANTOM1 participants will remember the vibrant
dynamism of the event, with night shifts of bioinformati-
cians creating useful annotation tools interspersed with
long brainstorming sessions to decide which cDNAs should
be annotated, as well as karaoke intervals to reset our
minds for the next round of annotations.
By 2001, we accomplished the annotation of the first set
of cDNAs (Kawai et al. 2001). In addition to their scientific
value in and of themselves, mouse cDNAs were also
instrumental in the identification of human coding genes
and were used for the gene prediction of the human gen-
ome, which was published (Lander et al. 2001) 1 week
after the FANTOM1 paper.
FANTOM2: The expansion of the full-length
cDNA collection
In parallel, our group continued the sequencing of full-
length cDNAs. By the time of the publication of the first
FANTOM manuscript, we had accumulated a much larger
but still growing collection of cDNA sequences. This
included the sequences that were derived from the sub-
tracted cDNA libraries, thus containing rare transcripts. In
the second FANTOM meeting in May 2002, we enlarged
the annotation to a total of approximately 60,770 full-
length cDNAs (Okazaki et al. 2002). The cDNA collection
was used for the annotation of the mouse genome
(Waterston et al. 2002), published back-to-back with our
cDNA collection, thereby demonstrating the importance of
full-length cDNA sequencing to annotate gene structure,
initiation, termination, and splicing variants in mammalian
genomes. Owing to the full-length cDNA subtraction
technologies (Carninci et al. 2000), the collection started to
reveal that there were unexpected transcripts, usually with
lower abundance, which did not appear to code for
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proteins. They were later identified as antisense RNA and
long non-coding RNAs (lncRNA).
A series of papers followed shortly after the release of
FANTOM2 collection including the first analysis of sense-
antisense transcription (Kiyosawa et al. 2003a, b) and
lncRNA (Numata et al. 2003), together with multiple
papers, published in a special issue of Genome Research, in
which specific aspects of particular interest were analyzed
covering various biological areas. This included the anal-
ysis of several major gene families that were for the first
time broadly covered by full-length cDNAs (summarized
in Okazaki and Hume 2003).
FANTOM3: Discovering the world of non-coding
RNA with CAGE
While we continued the sequencing of novel full-length
cDNAs, we also foresaw that the strong polymorphisms in
the 5’ end of sequenced transcripts would require the
comprehensive mapping and quantification of transcription
initiation sites (TSSs) in order to identify promoters and
their usage in different tissues and cells; this would also
help us to map transcriptional networks governing cell state
and identity. We, therefore, started to develop a high-
throughput method to map TSS that relied on concatenat-
ing short stretches of the 5’ end of full-length selected
cDNAs. Sequencing concatenations of 10–20 of such
sequence tags as single reads on the RISA 384 multicap-
illary sequencer allowed us to map TSSs at a reasonable
cost. This was the first version of the CAGE (Cap-analysis
gene expression) protocol (Shiraki et al. 2003), which has
been further developed and improved continuously since
its introduction. For example, oligo-(dT) priming was
replaced by random priming to enable the inclusion of
transcripts without poly-(A) tails (e.g., transcripts encoding
histones, lncRNAs) in the reverse transcription reaction
(Kodzius et al. 2006).
Using CAGE, we started to produce new type of data,
which were first analyzed in the summer of 2004.
Remarkably, CAGE analysis not only identified promoters
and quantified their activity and the expression of known
RNAs (Fig. 1a), but also more importantly, in conjunction
with the larger number of cDNAs, we realized that there
were many more RNAs in the mammalian transcriptome
than we previously thought (Fig. 1b). Complementing the
CAGE analysis with a paired-end tag sequencing method
(Wei et al. 2004), we discovered that the genome is per-
vasively transcribed—with more than 63 % of the genome
producing transcripts (Carninci et al. 2005), and more than
73 % of the genes showing some form of antisense tran-
scription (Katayama et al. 2005). The discovery of perva-
sive transcription was confirmed using an independent
technology based on tiling arrays for the human genome
(Cheng et al. 2005). Using CAGE, we produced the first
comprehensive promoter map both for human and mouse
(Carninci et al. 2006), which was accompanied by other
publications providing an in-depth analysis of chains of
genes that map continuously or overlapping on the genome
and are often co-regulated (Engstro¨m et al. 2006). CAGE
also enabled the discovery of different classes of promoter
architectures, revealing a significant overrepresentation of
TATA boxes in promoters showing sharp TSSs, which
were predominantly associated with tissue-specific tran-
scripts, whereas broad TSS regions were associated with
CpG islands and often corresponded to RNAs transcribed
across a wide range of cells and tissues (Carninci et al.
2006; Lenhard et al. 2012). Among other findings, CAGE
additionally provided a map of very large transcripts (Fu-
runo et al. 2006) and the first catalog of expressed pseu-
dogenes (Frith et al. 2006).
FANTOM4: Connecting the dots
by a transcriptional regulatory network
The appearance of next-generation sequencers (e.g.,
Roche-454) was instrumental in scaling up the production
of CAGE libraries (Valen et al. 2009), which allowed
sequencing of more than a million CAGE tags per sample,
a depth that was sufficient to enable the analysis of gene
networks. We centered the project on the dynamics of
cellular differentiation of the THP-1 cell line from mono-
blasts to monocytes by CAGE profiling in a time-course
experiment. The analysis of temporal CAGE data stimu-
lated the development of a new set of bioinformatics tools
that relied on the computational predictions of transcription
factor-binding sites (Arnold et al. 2012), which are typi-
cally enriched at specific positions with respect to the TSS.
The CAGE data guided the elucidation of the transcrip-
tional network by providing the location of the exact TSS
at single-nucleotide resolution and thereby pinpointing the
genomic location where transcription factor-binding sites
(TFBS) are most likely to be found. This study ultimately
led to the publication of the first transcriptional regulatory
networks based on CAGE analysis (Suzuki et al. 2009),
revealing a remarkably complex interplay of transcription
factors either activating or inhibiting each other (Fig. 2).
Unexpectedly, FANTOM4 generated several additional
important findings. For example, the discovery of tiny
RNAs (tiRNA) that map downstream of TSS; these RNAs
may have a regulatory role, or alternatively, be a side
product of transcription (Taft et al. 2009). Even more
surprisingly, by considering tags derived from retrotrans-
poson elements (REs)—which are usually discarded
because of mapping challenges—we found that REs are
M. de Hoon et al.: Paradigm shifts in genomics through the FANTOM projects 393
123
frequently transcribed in a very cell type specific and
reproducible manner (Faulkner et al. 2009). This provided
evidence that REs contain specific promoters driving the
transcription of coding and non-coding RNAs in various
tissues, especially in embryonic stages where LINE and
LTR elements are particularly active. The transcripts
derived from REs were further studied in later projects,
revealing their importance for stem cell maintenance (Fort
et al. 2014; Kelley and Rinn 2012). This discovery
underscores the importance of data-driven science in ana-
lyzing the experimental results, unbiased by preconcep-
tions of how cells should behave according to the
conventional biological knowledge: important conclusions
may be missed if looking for the expected outcome only,
and nature may surprise us by divulging its secrets in ways
not anticipated when the experiment was originally
designed.
FANTOM5: Complete landscape of human
and mouse promoterome
Next-generation sequencing further shaped the CAGE
technology (Kanamori-Katayama et al. 2011; Itoh et al.
2012; Takahashi et al. 2012), allowing the fifth edition of
FANTOM to return to the comprehensiveness of the earlier
A
B
Fig. 1 a An example of seven
alternative promoters within the
transcriptional unit of UDP-
glucuronyl transferase gene.
Light blue boxes indicate groups
of CAGE tags transcribed from
specific tissues. Reproduced,
with permission, from the
original publication (Carninci
et al. 2005). b The FANTOM3
work revealed that roughly
47 % of the transcribed RNAs
are messenger RNAs, encoding
for proteins, while 53 % of the
transcribed RNAs do not encode
for proteins. Numerous reports
since the discovery revealed that
non-coding RNAs are
functionally versatile and have
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FANTOM projects and to provide genome-wide tran-
scriptome maps covering very broad sets of human cell
types. FANTOM5 differed in two essential aspects from
the ENCODE project (The ENCODE Project Consortium
2012), which was in progress around the same time. First,
while ENCODE used immortalized cells in its analyses,
FANTOM5 used a wide variety of human primary cells
and tissues to capture the basic biology involved in
establishing and maintaining cell type identity (Fig. 3).
Second, while ENCODE encompassed many different
technologies to probe the human transcriptome and epi-
genome, FANTOM5 largely used CAGE as a single
readout of transcriptional activity, leveraging on data
published in other projects for complementary analysis (for
example, chromatin status in specific cell types); this
allowed us to detect TSS and therefore the regulatory
promoter regions both for coding and non-coding tran-
scripts, and at the same time to quantify their transcrip-
tional activity.
In the first phase of FANTOM5, we produced the largest
mammalian transcriptome atlas based on CAGE profiling
at single-nucleotide resolution (Forrest et al. 2014). This
revealed that mammalian promoters typically contain
multiple TSSs with different expression patterns across the
samples in the expression atlas, implying that these TSSs,
in spite of their proximity to each other, are regulated
separately. Promoters expressed ubiquitously in different
cell types showed the highest degree of conservation in the
promoter sequence, while the sequences of cell-specific
promoters tended to be less conserved.
As often happens, serendipity helps to discover novel
biological principles in the data. Previously, it had been
shown that enhancers are broadly marked by bidirectional
transcription (Kim et al. 2010; Djebali et al. 2012). In the
FANTOM5 data, however, we found that such enhancer-
derived RNAs (mostly non-coding RNA, for which the
function is still being debated) are expressed with a strong
tissue and cell specificity reflecting the activity of enhan-
cers. This led to the creation of a map of 44,000 active
enhancers (Andersson et al. 2014). In contrast to identify-
ing enhancers based on DNase hypersensitivity sites—
which may also be associated with other biological func-
tions—CAGE provided direct evidence for enhancer
activity.
Fig. 2 CAGE analysis in FANTOM4 revealed the concerted interplay of transcription factors during monocyte differentiation. Reproduced, with
permission, from the original publication (Suzuki et al. 2009)
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In the second phase of FANTOM5, we explored the
dynamics of enhancers and promoters by CAGE profiling
in 19 human and 14 mouse time-course experiments (Arner
et al. 2015). While these time courses encompassed a wide
diversity in cellular systems and included both their
response to external stimuli as well as differentiation pro-
cesses, in general, we found that the earliest response of
cells in these time courses occurred at enhancers, followed
shortly thereafter by the activation of the promoters of
genes coding for transcription factors.
As in previous FANTOM projects, the fifth edition of
FANTOM included a large number of satellite papers
exploring specific aspects of the data in more detail. Inte-
grating the FANTOM5 CAGE expression atlas with com-
plementary data such as ChIP-Seq and DNA methylation
profiling allowed us to study regulation in particular cell
types or processes. This led to the discovery of the con-
certed action of transcription factors, enhancers, and DNA
methylation during granulopoiesis (Ro¨nnerblad et al.
2014), the landscape of promoters and enhancers of clas-
sical, intermediate, and non-classical monocytes (Schmidl
et al. 2014), the interplay of DNA methylation and tran-
scriptional regulation by Foxp3 in regulatory T-cells
(Morikawa et al. 2014), and the role of bone morpho-
genetic protein receptors in the activation of mast cells
(Motakis et al. 2014). On a global scale, analyzing the
transcriptome output of human cells across the FANTOM5
compendium enabled us to understand the contribution of
protein evolution to cell type identity (Sardar et al. 2014),
as well as the essential role of promoter architecture in
explaining the ubiquity of gene expression across human
cell types (Hurst et al. 2014).
To facilitate the analysis of this large compendium of
transcriptome data, we developed the Zenbu visualization
system (Severin et al. 2014), allowing the fast browsing of
large next-generation sequencing datasets, detailed
inspection of expression levels of thousands of experiments
at particular genomic loci, as well as data sharing for
specific collaborations.
The unprecedented deep CAGE sequencing efforts in
the FANTOM and ENCODE projects, together with other
genome-wide profiling efforts, led to a revolution in our
Fig. 3 FANTOM5 profiled the broadest collection of human cell types using CAGE; the co-expression network shown here revealed clusters of
cell types based on similar function and developmental lineages. Reproduced, with permission, from the original publication (Forrest et al. 2014)
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understanding of the mammalian transcriptome. In stark
contrast to the earlier view of non-coding parts of the
genome as transcriptional deserts composed of junk DNA,
Djebali et al. (2012) showed that at least 75 % of the
human genome can be transcribed. Likewise, the FAN-
TOM projects revealed the existence of transcriptional
forests of overlapping transcripts on both strands of the
DNA (Carninci et al. 2005) instead of genes with well-
defined genomic start and end positions. This raises the
question of the definition of a gene, in particular as tran-
scripts can overlap multiple genes (Djebali et al. 2012).
The complexity of the mammalian genome is further
highlighted by the discovery of CAGE tags in unexpected
regions, for example, across exon–exon boundaries. These
CAGE tags were found to be due to recapping after RNA
processing (Fejes-Toth et al. 2009); the biological function
of these recapped transcript has not yet been determined.
Integration of information obtained from CAGE with
genome-wide data produced by complementary technolo-
gies is instrumental in interpreting the patterns observed in
the data. For example, histone three acetylation profiling
demonstrated that the exon-crossing CAGE tags are not
due to independent transcriptional events (Fejes-Toth et al.
2009). Other examples include the combination of CAGE
data with RNAseq experiments to connect transcription
initiation events to novel transcript models (Djebali et al.
2012), as well as the confirmation of novel promoters
identified using CAGE by H3K4 trimethylation marks and
DNase hypersensitivity (Forrest et al. 2014), and CAGE-
defined enhancers by H3K4 monomethylation and H3K27
acetylation (Andersson et al. 2014).
FANTOM 6: Pioneering the world of lncRNAs
While the FANTOM projects revealed a plethora of
lncRNAs, the biological functions of these transcripts
remain largely unknown. Currently, there is no reference in
PubMed for more than 98 % of lncRNAs in Gencode
(Harrow et al. 2012) (Fig. 4)—though this is a very con-
servative set of lncRNAs representing only a fraction of the
tens of thousands of lncRNAs discovered in recent large-
scale projects such as FANTOM, ENCODE (Djebali et al.
2012), and TCGA (Iyer et al. 2015), as well as FANTOM5
datasets yet to be published. At the same time, the
lncRNAs that have been functionally characterized
demonstrate that they have key roles across diverse bio-
logical processes, including the regulation of transcription,
translation, the epigenome, and chromatin. For example,
the lncRNA HOTAIR is involved in the genomic targeting
of chromatin-modifying factors by scaffolding the assem-
bly of ribonuclear proteins complexes (Rinn et al. 2007),
suggesting that lncRNAs may be the adapters that drive the
epigenome machinery to specific targets by providing a
genomic zip code, yet to be decoded. More recently, we
found an lncRNA transcript that regulates the level of
translation of a protein-coding gene on the opposite strand
of DNA; surprisingly, a SINEB2 repeat element tran-
scribed as part of the lncRNA was found to be essential for
its regulatory role in the cytoplasm (Carrieri et al. 2012).
Such lncRNA were named SINEUPs, as they contain SINE
elements that specifically UP-regulate translation. These
lncRNAs be further artificially engineered to specifically
enhance translation of targeted proteins (Patrucco et al.
2015; Zucchelli et al. 2015). These examples show that
lncRNAs form direct interactions with proteins and com-
plexes that are dynamic and can create specificity and
control in regulation, and can thus be regarded as the
master regulators of cellular function. Given that funda-
mental questions of biological regulation cannot yet be
addressed by the protein-coding world, we believe that
exploration of lncRNA function is essential to uncover
regulatory elements.
However, attempts to comprehensively characterize the
function of lncRNAs will be challenging. First of all, the
definition of non-coding RNAs as transcripts that do not
code for proteins is fundamentally based on what they are
not, and it remains unknown whether this class of RNAs
possesses any other encompassing characteristic. Long
non-coding RNAs vary enormously in size: whereas
lncRNAs are conventionally distinguished from short
RNAs by having a length over 200 nucleotides (Kapranov
et al. 2007; Wang and Chang 2011), very long intergenic
non-coding RNAs (vlincRNAs) can span more than 1 MB
(Furuno et al. 2006; St Laurent et al. 2013). In contrast to
Fig. 4 On December 8, 2014 we counted the number of references in
PubMed for protein-coding and non-coding genes in release 21 of the
GENCODE human gene set. Non-coding genes comprise of both
lincRNAs and antisense transcripts as listed in GENCODE. We found
multiple PubMed references for most protein-coding genes; in
contrast, most non-coding RNAs did not have any reference in
PubMed
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coding transcripts, which are predominantly cytosolic, non-
coding RNA tends to be localized to the nucleus (Djebali
et al. 2012), where the transcriptome is particular complex
(Cheng et al. 2005, Kapranov et al. 2007, Fort et al. 2014).
On average, lncRNAs have lower expression levels than
protein-coding transcripts, with more than 80 % of
lncRNAs detected in the ENCODE cell lines present at less
than 1 copy per cell (Djebali et al. 2012). We note though
that the expression varies by orders of magnitude levels
between non-coding RNAs; as an example, the lncRNA
MALAT1 was one of the most abundant RNAs across the
FANTOM5 samples (Forrest et al. 2014). In addition,
lncRNAs that appear lowly expressed overall may be
highly expressed in particular cells, or be abundant in
specific compartments of the nucleus.
In the case of protein-coding genes, we can often assign
a tentative function to novel transcripts by analyzing the
encoded amino-acid sequence either based on their global
similarity to known proteins or by the identification of
specific protein domains. In contrast, the primary sequence
of nucleotides of lncRNAs is much less informative than
the amino-acid sequence of protein-coding genes, pre-
venting us in virtually all cases from assigning a function to
novel non-coding transcripts. Additionally, lncRNAs are
poorly conserved across organisms, at least at the primary
nucleotide sequence level, suggesting that a comparative
analysis to understand lncRNA function will not be trivial,
and will need the development of novel comparative
analysis methodologies specifically designed for investi-
gating lncRNA functionality, as well as methods to explore
three-dimensional folding similarities of RNAs.
Given these challenges, even the most fundamental
questions regarding the function of most lncRNAs remain
unanswered. As an example, the proportion of the lncRNAs
that are empirically functional is currently a topic of
intense debate. But also the general principles of lncRNA
biology are unknown. For example, given that proteins can
be classified into homologous groups with similar func-
tions, can we likewise designate classes of lncRNAs based
on their function, functional domains, mechanism, and
mode of operation? If so, how many classes are there, what
are their common functions or mechanisms, and how are
they integrated in the global regulatory networks governing
cellular behavior? Finally, do the unique physical proper-
ties of RNA allow lncRNAs to be functional in ways that
proteins cannot? In particular, whereas proteins comprise
multiple functional domains characterized by properly
folded structures, lncRNAs typically combine folded
functional domains with unstructured functional regions
that may base-pair with other nucleic acids, including
genomic DNA, and may thus provide ribonucleoprotein
complexes exquisite target specificity in a manner funda-
mentally different from direct binding of proteins to DNA.
Answering these questions will require a global
approach to interrogate a large collection of lncRNAs to
substantiate their importance and to elucidate their role in
the central regulation of the mammalian genome. Because
of challenges associated with developing appropriate
assays for yet-to-be described functions, we envision a
FANTOM6 project based on high-throughput screening
(HTS) of lncRNAs followed by molecular phenotyping by
CAGE to assess lncRNA function in multiple cell types.
Moreover, development and integration of novel tech-
nologies will undoubtedly be key to the success of this
large-scale effort. In addition to HTS and CAGE, tech-
nologies to decipher the secondary structures of lncRNAs
(e.g., Parallel analysis of RNA structure (PARS); Kertesz
et al. 2010), their associations to chromatin and proteins
(e.g., chromatin isolation by RNA purification (Chu et al.
2011) or Hi-C sequencing to map long-range interactions
in the genome (Lieberman-Aiden et al. 2009)) will be
instrumental in understanding the mechanistic insights into
their mode of action. Overall, the functional screening and
molecular phenotyping by CAGE will be essential to
characterize lncRNA that is involved in various biological
processes both in health and disease.
Conclusions
The traditional approach of characterizing one gene func-
tion at a time has been inefficient and oftentimes incom-
plete, requiring the production of a large amount of data for
a single project with little chances to be reused. Among
other consortiums, FANTOM has strongly contributed for
creating the necessary resources to broadly categorize
genes and their regulatory relationships. For example, the
FANTOM website (http://fantom.gsc.riken.jp) and the
ZENBU Genome browser (http://fantom.gsc.riken.jp/
zenbu; Severin et al. 2014) are visited frequently, with
almost 10 million accesses between May 2014 and April
2015, and the publications derived from FANTOM have
been cited 11,855 times since the creation of the consor-
tium. We believe that four main factors have contributed to
the success of the FANTOM projects. First, development
of original technologies, such as full-length cDNA cloning
and CAGE, has enabled the production of original datasets
that were not previously available. Under the umbrella of a
large research institute such as RIKEN, it has been feasible
to develop a new generation of technologies without the
pressure to publish in the short term, to which smaller
research groups are often exposed. Second, the critical
mass of RIKEN staff with a wide variety of expertise was
needed to streamline the technology and data production
before launching into large-scale production (e.g., Kawaji
et al. 2014). Because of the immense scale of the
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FANTOM projects, we ensured to provide easy access to
well-standardized technologies and data to many labora-
tories; this invitation has attracted excellent collaborators
to further strength the consortium. Third, the scientific
coordination of the FANTOM consortium with a wide
range of expertise that went beyond the field of genomics
was essential. In-depth and lively discussions with experts
from various research backgrounds (e.g., immunology,
neurobiology, developmental biology, stem cell biology,
and also different types of bioinformatics and data analy-
sis) have been instrumental in generating unique and novel
interpretations of omics data; through this collective effort
of the consortium, we were able to overcome new chal-
lenges and expand the minds of the scientific community as
a whole. This scientific model further promoted consor-
tium-centered landmark publications followed by a large
number of specialized reports. Fourth, pioneering toward
new biological aims has sustained the consortium over
15 years, from the shear collection of genomic elements in
the earlier FANTOM projects to the analysis of gene reg-
ulation and function in later FANTOM projects. Develop-
ing key technologies to address evolving biological goals
has thus been critical to the success of the consortium. We
believe that further development of single cell method-
ologies and functional characterization of non-coding
RNAs will play important roles in the future chapters of
FANTOM. In conclusion, the FANTOM collaborative
research model can be further implemented toward other
biological aspects, ranging from elucidating cellular
heterogeneity to understanding individual diversity in
health and disease.
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